archive-com.com » COM » V » VENTUREVALUATION.COM

Total: 41

Choose link from "Titles, links and description words view":

Or switch to "Titles and links view".
  • Valuation process | Venture Valuation
    company s strategy We will then conduct an on site workshop usually with two specialists from Venture Valuation and the appropriate members of the company s management team The meeting normally begins with a short presentation by the company s management and a discussion of the crucial factors related to the valuation During the meeting we also give support related to strategic decisions using the value based management approach Depending on the company as well as the available documents this meeting will last half a day to two days The information we generally require for a valuation includes but is not limited to The business plan The budget 3 to 5 year forecast The CVs of the management The development timelines for biotechnology companies The IP situation Prior to the meeting you will be provided with a complete list of information that we would preferably require from you The Valuation Report is then written based on all accumulated information External data such as market customer partner and supplier information is also considered As experience shows the writing of a Valuation Report is an interactive procedure between us and the management team therefore continuous contact and information exchange is maintained We

    Original URL path: http://www.venturevaluation.com/en/methodology/valuation-process (2016-04-25)
    Open archived version from archive


  • About us | Venture Valuation
    remained true to its mission the independent assessment and valuation of companies products and patents Our focus is on technology companies in fast growing markets and industries including pharmaceuticals Biotechnology Medical Technology Med Tech nanotechnology renewable energies cleantech and information technology IT computer science software Our clients include companies domiciled on almost all continents We perform reviews both for investors as well as for companies themselves In addition to our assessment services in Life Sciences in 2003 we established the Swiss Life Sciences Database the cornerstone of our global company and Licensing Deal database Biotechgate www biotechgate com Biotechgate is now an independent business unit within Venture Valuation The portal has become a premier information hub Information Broker for all potential stakeholders in the biotechnology pharmaceutical and medical technology fields A wealth of data on life science related companies products licensing opportunities licensing deals financing financing rounds and much more can be viewed analysed processed and downloaded At Venture Valuation we always place experienced internal consultants and analysts in all the services we offer In addition to the scientific expertise our experts provide we also rely on a network of established partners to meet all of your needs This allows

    Original URL path: http://www.venturevaluation.com/en/about-us (2016-04-25)
    Open archived version from archive

  • Team | Venture Valuation
    MIT TR35 Innovator of the Year award by the Massachusetts Institute of Technology She was chosen among the top 100 women leaders in Spain in the entrepreneurial and innovative category for two consecutive years in 2012 and 2013 She was also selected as Woman of the Year by the magazine Scientific entrepreneurial Woman Today For her work mentoring startups IE Business School awarded her the prize for best Mentor of the year Mark Farrelly Online Marketing Manager M A Mark is based in Ireland and joined Venture Valuation in early 2016 working as the online and marketing manager He previously worked as editor of Irish sports website Balls ie and as a journalist with the likes of WorldIrish com A graduate of Maynooth University he holds a Masters in Society and Space along with a BA in English and Geography Ronald E Layden Senior Advisor VP Life Sciences Ph D Ron joined Venture Valuation in 2001 and is mainly involved in company and product valuations and assessment His previous roles include CEO of a biotechnology company venture capitalist and co founder of several businesses senior manager in the pharmaceutical industry with assignments at Roche Bayer and Eli Lilly He also has research and laboratory experience in oil field chemistry cell biology molecular biology and genetics Ron holds a Ph D in Biochemistry from the University of Western Ontario in Canada Alan Jones Senior Business Development Executive Alan joined Venture Valuation in 2012 he is responsible for conducting business development for the Biotechgate database which is a global comprehensive information service encompassing the Life Science industry Alan has extensive experience in the business development of innovative information services within the life sciences and previously worked for many years within the business development team at Pharmalicensing Barbara Cambridge Business Development Executive Barbara joined Venture Valuation in early 2014 She has vast experience in multiple roles for a number of life science companies Barbara is now a part of the Biotechgate business development team and is also responsible for the companies social media activities Wim Troch Business Development Executive M A Wim is multi lingual with many years of business development experience within several sectors and hopefully the best is still to come He started his career in London after which his professional travels took him to Russia Spain Australia and recently to Switzerland He has over 5 years experience in the Life Science sector Pravin Krishnan Business Development Executive BSc Hons Pravin graduated with a honours degree in Biological Sciences from the University of Liverpool Currently based in Singapore he has worked in Sydney Kuala Lumpur Liverpool and London over the last 7 years in various commercial positions Pravin is experienced at managing multinational clients in emerging markets such as APAC as well as established regions Having grown up in Asia he possesses unique knowledge and understanding of the different cultures in the region combined with experience in a business development capacity in the life science industry among others He joined Venture

    Original URL path: http://www.venturevaluation.com/en/about-us/team (2016-04-25)
    Open archived version from archive

  • References | Venture Valuation
    II L P UK Private equity fund target USD 750m with investments in the pharmaceutical and biotechnology sectors Esperante UK Early stage investor European Investment Bank EIB Luxembourg European Union s financing institution Family Office Germany Biotech focused private investor GSK CEEDD UK Part of Alternative Discovery and Development Unit ADD within GSK HP NCICube Switzerland Corporate Investor incubator of Hewlett Packard Novartis Venture Fund Switzerland Corporate Investor of Novartis International AG Undisclosed UK and French Well established international Biotech Investors Unirisco Uninvest Spain Spanish Investor Companies 4SC Germany Public Xetra VSC Biotech company Crohn s disease cancer therapeutics Adcom Group AG Switzerland Multimedia company production of CD ROMs several services Ambrilia Canada Public TSE AMB Biotech company cancer therapeutics APR Applied Pharma Research Switzerland Pharma company Arpida Evolva Switzerland Fairness opinion on merger Biotech company Axxam SpA Italy Biotech company HTS discovery Biolytix AG Switzerland Biotech company molecular analysis ChemOvation UK Biotech company combinatorial chemistry Destiny Pharma UK Biotech company licensing of patents Discovery Genomics Inc USA Biotech company functional genomics Esbatec Switzerland Biotech company antibody fragments today owned by Alcon Novartis Fachhochschule Salzburg Austria University IT Communication Digital TV Genedata AG Switzerland Biotech company bioinformatics Photonfocus AG Switzerland

    Original URL path: http://www.venturevaluation.com/en/references/clients (2016-04-25)
    Open archived version from archive

  • Contact | Venture Valuation
    CH 8004 Zurich Switzerland Phone 41 43 321 86 60 Fax 41 43 321 86 61 Email Asia Singapore Venture Valuation VV Asia Pte Ltd 165 Bukit Merah Central 05 3679 Singapore 150165 Phone 65 31 590 721 North America Canada Venture Valuation Inc 444690 Cuthbert Rd Ingersoll ON N5C 3J8 Canada Susanne E Acklin Senior Advisor VP Life Sciences Phone 1 519 495 54 49 Fax 1 514 371

    Original URL path: http://www.venturevaluation.com/en/contact (2016-04-25)
    Open archived version from archive

  • Global Valuation Services | Venture Valuation
    hier für mehr informationen Global Valuation Services Valuation Unternehmensbewertung Wir bewerten Unternehmen für Investitionsverhandlungen oder bei Zusammenschlüssen und Akquisitionen M A Produktbewertung Wir berechnen den Wert von Produkten und Patenten nach dem rNPV Modell Portfolio Bewertung Wir unterstützen Sie beim Reporting und Monitoring von Investitions Portfolios Partnering Partnersuche Biotech Medtech Wir identifizieren für Sie mögliche Geschäftspartner im Biotech Pharma oder Medtech Bereich Assessment Company Assessment Wir ermitteln die wichtigen Erfolgsfaktoren

    Original URL path: http://www.venturevaluation.com/de (2016-04-25)
    Open archived version from archive

  • Company Valuation | Venture Valuation
    can ultimately determine the success of a given transaction Identifying the crucial value drivers behind your business model is a key to success We can help you clarify and identify these critical factors with a thorough assessment of your financials technology market and management Our valuation process will not only provide you with an objective evaluation of your company but will also present you with valuable feedback about how you can increase its long term and to prepare you for key questions you will be asked by potential investors Risk analysis and company financials make up an integral part of our valuation We consider hard data as well as soft factors when conducting our risk analysis The financial aspect of the valuation is then performed using a variety of accepted and proven methods Depending on the specific circumstances of the company a combination of the following methods is used Discounted cash flow DCF method Risk adjusted Net Present Value rNPV method Venture capital method Market comparable method Comparable transactions method Decision Tree valuation Real options method Sum of parts valuation As a third party appraiser we can help you find a basis for your negotiations with an independent valuation and

    Original URL path: http://www.venturevaluation.com/en/services/valuation/company-valuation (2016-04-25)
    Open archived version from archive

  • Product Valuation | Venture Valuation
    royalties on licensing deals can also be useful tools in the negotiation process We can help you to prioritize your products analyze the risk return for each project and compare the needed investment with the potential return You will receive A detailed assessment of your technology and market The calculated risk adjusted net present value rNPV of your IP or product A scenario and sensitivity analysis including various possible deal

    Original URL path: http://www.venturevaluation.com/en/services/valuation/product-valuation (2016-04-25)
    Open archived version from archive



  •